KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gilead Sciences (GILD) Enterprise Value (2016 - 2025)

Gilead Sciences' Enterprise Value history spans 17 years, with the latest figure at -$7.7 billion for Q4 2025.

  • For Q4 2025, Enterprise Value rose 23.41% year-over-year to -$7.7 billion; the TTM value through Dec 2025 reached -$7.7 billion, up 23.41%, while the annual FY2025 figure was -$7.7 billion, 23.41% up from the prior year.
  • Enterprise Value reached -$7.7 billion in Q4 2025 per GILD's latest filing, down from -$7.4 billion in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$2.9 billion in Q2 2024 to a low of -$10.1 billion in Q4 2024.
  • Average Enterprise Value over 5 years is -$6.3 billion, with a median of -$6.2 billion recorded in 2022.
  • Peak YoY movement for Enterprise Value: surged 76.04% in 2021, then plummeted 85.47% in 2025.
  • A 5-year view of Enterprise Value shows it stood at -$6.5 billion in 2021, then increased by 1.67% to -$6.4 billion in 2022, then decreased by 14.53% to -$7.3 billion in 2023, then crashed by 37.11% to -$10.1 billion in 2024, then rose by 23.41% to -$7.7 billion in 2025.
  • Per Business Quant, the three most recent readings for GILD's Enterprise Value are -$7.7 billion (Q4 2025), -$7.4 billion (Q3 2025), and -$5.3 billion (Q2 2025).